SCHEMBL5777535

SCHEMBL5777535

Cc1nc(-c2ccsc2)c2nc(-c3ccccc3)cc-2[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 1/20 0.51
ADORA1 P30542 3/20 0.42
ADORA2A P29274 3/20 0.42
ADORA3 P0DMS8 1/20 0.42
KDM4E B2RXH2 5/20 0.41
HPGD P15428 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ALDH1A1 P00352 3/20 0.40
POLB P06746 2/20 0.40
MEN1 O00255 1/20 0.40
MAPT P10636 1/20 0.40
PKM P14618 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
CYP2E1 P05181 1/20 0.40
CYP2A6 P11509 1/20 0.40
CYP2B6 P20813 1/20 0.40
HSD17B10 Q99714 2/20 0.39
CDC7 O00311 1/20 0.38
TDO2 P48775 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5774277 0.79 MAPT (0.46) ADORA1ADORA2AADORA3KDM4EHPGD
SCHEMBL5772874 0.78 KDM4E (0.47) ADORA1ADORA2AADORA3KDM4EHPGD
SCHEMBL5776173 0.77 NPY5R (0.51) NPY5RADORA1ADORA2AADORA3KDM4E
SCHEMBL5775603 0.77 ADORA3 (0.50) ADORA1ADORA2AADORA3KDM4EHPGD
SCHEMBL5771657 0.77 PDPK1 (0.45) ADORA1ADORA2AADORA3KDM4EHPGD
SCHEMBL5774390 0.76 KDM4E (0.59) KDM4EHPGDSMN1; SMN2ALDH1A1MAPT
SCHEMBL5772983 0.76 KDM4E (0.49) NPY5RADORA1ADORA2AADORA3KDM4E
SCHEMBL5796755 0.75 ADORA3 (0.43) ADORA1ADORA2AADORA3KDM4EHPGD
SCHEMBL5774543 0.75 ADORA1 (0.48) ADORA1ADORA2AADORA3KDM4EHPGD
SCHEMBL5771758 0.75 ADORA2A (0.48) NPY5RADORA1ADORA2AADORA3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP disclosed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US disclosed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US disclosed
EP-1054887-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS Amgen Inc. (US) 2000-11-29 EP disclosed
WO-1999040091-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC. (US) 1999-08-12 WO disclosed